Is the VA the Key to Healthcare Reform?
To find out the answer to this question–ok, a partial answer–listen to my appearance on the NPR show The Takeaway. CLICK HERE.
To find out the answer to this question–ok, a partial answer–listen to my appearance on the NPR show The Takeaway. CLICK HERE.
The Harvard faculty recently raised a stink because their benefits now require them to pay out-of-pocket for some of their medical care. Physician appointments will no longer be free, but will cost $20. And Harvard faculty will be expected to pay 10% of the cost of many medical services, up to a maximum of $1500…
In a recent Forbes post, I wrote about geographical variation in healthcare expenses, and pointed out that a lot of this variation occurs after people leave hospitals. That’s when people end up in nursing homes, rehabilitation facilities and the like. Well it turns out, not only is there great variation in these expenses, but these…

If you thought donuts were bad for your health, consider donut holes. Specifically, the donut hole sitting smack in the middle of Medicare Part D, the program helping senior citizens pay for their medications. The donut hole is a gap in coverage causing people, once they’ve received a certain level of financial support for their prescriptions, to have to go it alone for a while, bea
read more
View original post and comments at Scientocracy
The hospital price transparency bill that was signed into effect on August 21 has elicited criticism from the Duke health community. House Bill 834 mandates that hospitals and medical care agencies in North Carolina—including Duke University Medical Center—provide pricing information on 140 of the most common health care procedures to the Department of Health and…
I have been writing a lot lately about out-of-pocket costs for health care in United States. In my research on this topic, I came across the following picture, which shows how much insurers are spending on healthcare, among people in the United States receiving insurance through their employers, and also how much those employees are spending…
The state of California is suing Gilead Sciences over its delay of an HIV drug, a move that critics of the pharmaceutical industry call “product hopping.” Regardless of how the lawsuit comes out, the company’s actions strike me as deeply immoral and ought to leave all of us hopping mad. Here’s what we know.